Literature DB >> 32162336

Annual report to the nation on the status of cancer, part I: National cancer statistics.

S Jane Henley1, Elizabeth M Ward2, Susan Scott3, Jiemin Ma4, Robert N Anderson5, Albert U Firth6, Cheryll C Thomas1, Farhad Islami4, Hannah K Weir1, Denise Riedel Lewis3, Recinda L Sherman2, Manxia Wu1, Vicki B Benard1, Lisa C Richardson1, Ahmedin Jemal4, Kathleen Cronin3, Betsy A Kohler2.   

Abstract

BACKGROUND: The American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate to provide annual updates on cancer occurrence and trends in the United States.
METHODS: Data on new cancer diagnoses during 2001 through 2016 were obtained from the Centers for Disease Control and Prevention-funded and National Cancer Institute-funded population-based cancer registry programs and compiled by the North American Association of Central Cancer Registries. Data on cancer deaths during 2001 through 2017 were obtained from the National Center for Health Statistics' National Vital Statistics System. Trends in incidence and death rates for all cancers combined and for the leading cancer types by sex, racial/ethnic group, and age were estimated by joinpoint analysis and characterized by the average annual percent change during the most recent 5 years (2012-2016 for incidence and 2013-2017 for mortality).
RESULTS: Overall, cancer incidence rates decreased 0.6% on average per year during 2012 through 2016, but trends differed by sex, racial/ethnic group, and cancer type. Among males, cancer incidence rates were stable overall and among non-Hispanic white males but decreased in other racial/ethnic groups; rates increased for 5 of the 17 most common cancers, were stable for 7 cancers (including prostate), and decreased for 5 cancers (including lung and bronchus [lung] and colorectal). Among females, cancer incidence rates increased during 2012 to 2016 in all racial/ethnic groups, increasing on average 0.2% per year; rates increased for 8 of the 18 most common cancers (including breast), were stable for 6 cancers (including colorectal), and decreased for 4 cancers (including lung). Overall, cancer death rates decreased 1.5% on average per year during 2013 to 2017, decreasing 1.8% per year among males and 1.4% per year among females. During 2013 to 2017, cancer death rates decreased for all cancers combined among both males and females in each racial/ethnic group, for 11 of the 19 most common cancers among males (including lung and colorectal), and for 14 of the 20 most common cancers among females (including lung, colorectal, and breast). The largest declines in death rates were observed for melanoma of the skin (decreasing 6.1% per year among males and 6.3% among females) and lung (decreasing 4.8% per year among males and 3.7% among females). Among children younger than 15 years, cancer incidence rates increased an average of 0.8% per year during 2012 to 2016, and cancer death rates decreased an average of 1.4% per year during 2013 to 2017. Among adolescents and young adults aged 15 to 39 years, cancer incidence rates increased an average of 0.9% per year during 2012 to 2016, and cancer death rates decreased an average of 1.0% per year during 2013 to 2017.
CONCLUSIONS: Although overall cancer death rates continue to decline, incidence rates are leveling off among males and are increasing slightly among females. These trends reflect population changes in cancer risk factors, screening test use, diagnostic practices, and treatment advances. Many cancers can be prevented or treated effectively if they are found early. Population-based cancer incidence and mortality data can be used to inform efforts to decrease the cancer burden in the United States and regularly monitor progress toward goals.
© 2020 American Cancer Society.

Entities:  

Keywords:  Annual Report to the Nation; Epidemiology; National Program of Cancer Registries (NPCR); National Vital Statistics System (NVSS); North American Association of Central Cancer Registries (NAACCR); Surveillance; and End Results (SEER) program; cancer; epidemiology; incidence; mortality; trends

Mesh:

Year:  2020        PMID: 32162336      PMCID: PMC7299151          DOI: 10.1002/cncr.32802

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.921


  50 in total

1.  The past, present, and future of cancer incidence in the United States: 1975 through 2020.

Authors:  Hannah K Weir; Trevor D Thompson; Ashwini Soman; Bjørn Møller; Steven Leadbetter
Journal:  Cancer       Date:  2015-02-03       Impact factor: 6.860

2.  Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.

Authors:  Albert L Siu
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

3.  Epidemiologic Signatures in Cancer.

Authors:  H Gilbert Welch; Barnett S Kramer; William C Black
Journal:  N Engl J Med       Date:  2019-10-03       Impact factor: 91.245

4.  Body Fatness and Cancer--Viewpoint of the IARC Working Group.

Authors:  Béatrice Lauby-Secretan; Chiara Scoccianti; Dana Loomis; Yann Grosse; Franca Bianchini; Kurt Straif
Journal:  N Engl J Med       Date:  2016-08-25       Impact factor: 91.245

5.  Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage.

Authors:  Janet S de Moor; Robin A Cohen; Jean A Shapiro; Marion R Nadel; Susan A Sabatino; K Robin Yabroff; Stacey Fedewa; Richard Lee; V Paul Doria-Rose; Cheryl Altice; Carrie N Klabunde
Journal:  Prev Med       Date:  2018-05-03       Impact factor: 4.018

6.  Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies.

Authors:  Jie Ma; Min Huang; Li Wang; Wei Ye; Yan Tong; Hanmin Wang
Journal:  Med Sci Monit       Date:  2015-01-22

7.  Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.

Authors:  Ahmedin Jemal; Elizabeth M Ward; Christopher J Johnson; Kathleen A Cronin; Jiemin Ma; Blythe Ryerson; Angela Mariotto; Andrew J Lake; Reda Wilson; Recinda L Sherman; Robert N Anderson; S Jane Henley; Betsy A Kohler; Lynne Penberthy; Eric J Feuer; Hannah K Weir
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 13.506

8.  Uterine Cancer Incidence and Mortality - United States, 1999-2016.

Authors:  S Jane Henley; Jacqueline W Miller; Nicole F Dowling; Vicki B Benard; Lisa C Richardson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-12-07       Impact factor: 17.586

9.  Challenges in meeting Healthy People 2020 objectives for cancer-related preventive services, National Health Interview Survey, 2008 and 2010.

Authors:  Martin L Brown; Carrie N Klabunde; Kathy A Cronin; Mary C White; Lisa C Richardson; Timothy S McNeel
Journal:  Prev Chronic Dis       Date:  2014-02-27       Impact factor: 2.830

10.  Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity - United States, 2005-2014.

Authors:  C Brooke Steele; Cheryll C Thomas; S Jane Henley; Greta M Massetti; Deborah A Galuska; Tanya Agurs-Collins; Mary Puckett; Lisa C Richardson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-10-03       Impact factor: 17.586

View more
  172 in total

1.  Response to Lehrer and Rheinstein.

Authors:  Stacey A Fedewa; Jiemin Ma; Ahmedin Jemal
Journal:  J Natl Cancer Inst       Date:  2020-10-01       Impact factor: 13.506

2.  Assessing the applications of transitional care and its impact on the quality of life in patients after total laryngectomy.

Authors:  Yingchao Zhu; Dong Chen; Lili Jiang; Leilei Yu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Prostate Cancer: Community Education and Disparities in Diagnosis and Treatment.

Authors:  Bradley Carthon; Hannah C Sibold; Shannon Blee; Rebecca D Pentz
Journal:  Oncologist       Date:  2021-03-22

4.  Cancer Mortality Disparities among Asian American and Native Hawaiian/Pacific Islander Populations in California.

Authors:  Heidy N Medina; Karen E Callahan; Cyllene R Morris; Caroline A Thompson; Adugna Siweya; Paulo S Pinheiro
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04-20       Impact factor: 4.254

5.  The National Cancer Institute's Role in Advancing Health-Care Delivery Research.

Authors:  Paul B Jacobsen; Janet de Moor; V Paul Doria-Rose; Ann M Geiger; Sarah C Kobrin; Annie Sampson; Ashley Wilder Smith
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 13.506

6.  Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib.

Authors:  Dylan J Martini; Meredith R Kline; Yuan Liu; Julie M Shabto; Bradley C Carthon; Greta Anne Russler; Lauren Yantorni; Emilie Elise Hitron; Sarah Caulfield; Jamie M Goldman; Wayne B Harris; Omer Kucuk; Viraj A Master; Mehmet Asim Bilen
Journal:  Cancer Treat Res Commun       Date:  2021-05-09

Review 7.  Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy.

Authors:  Morgan E Lorkowski; Prabhani U Atukorale; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Healthc Mater       Date:  2020-11-23       Impact factor: 9.933

8.  A UVB-responsive common variant at chromosome band 7p21.1 confers tanning response and melanoma risk via regulation of the aryl hydrocarbon receptor, AHR.

Authors:  Mai Xu; Lindsey Mehl; Tongwu Zhang; Rohit Thakur; Hayley Sowards; Timothy Myers; Lea Jessop; Alessandra Chesi; Matthew E Johnson; Andrew D Wells; Helen T Michael; Patricia Bunda; Kristine Jones; Herbert Higson; Rebecca C Hennessey; Ashley Jermusyk; Michael A Kovacs; Maria Teresa Landi; Mark M Iles; Alisa M Goldstein; Jiyeon Choi; Stephen J Chanock; Struan F A Grant; Raj Chari; Glenn Merlino; Matthew H Law; Kevin M Brown
Journal:  Am J Hum Genet       Date:  2021-08-02       Impact factor: 11.025

9.  Toxicity and antitumor activity of novel agents in elderly patients with cancer included in phase 1 studies.

Authors:  Geriletu Ao; Maria de Miguel; Ana Gomes; Runhan Liu; Valentina Boni; Irene Moreno; José Miguel Cárdenas; Antonio Cubillo; Lisardo Ugidos; Emiliano Calvo
Journal:  Invest New Drugs       Date:  2021-07-21       Impact factor: 3.850

10.  Dietary Melatonin and Omega-3 Fatty Acids Induce Human Cancer Xenograft Regression In Vivo in Rats by Suppressing Linoleic Acid Uptake and Metabolism.

Authors:  Erin M Dauchy; Robert T Dauchy; Robert P Tirrell; Leslie K Davidson; Steven M Hill; Leonard A Sauer; David E Blask
Journal:  Comp Med       Date:  2021-06-29       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.